TR200101348T2 - Yeni tedavi metodu - Google Patents

Yeni tedavi metodu

Info

Publication number
TR200101348T2
TR200101348T2 TR2001/01348T TR200101348T TR200101348T2 TR 200101348 T2 TR200101348 T2 TR 200101348T2 TR 2001/01348 T TR2001/01348 T TR 2001/01348T TR 200101348 T TR200101348 T TR 200101348T TR 200101348 T2 TR200101348 T2 TR 200101348T2
Authority
TR
Turkey
Prior art keywords
treatment method
new treatment
diabetes
plasma concentration
threshold
Prior art date
Application number
TR2001/01348T
Other languages
English (en)
Inventor
Benincosa Lisa
Jusko William
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10842389&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200101348(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200101348T2 publication Critical patent/TR200101348T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Insülin sensitizörünün etkili plazma seviyeleri araliginda, en azindan esik degerinde bir plazma konsantrasyonunu (Esik Plazma Konsantrasyonu) saglamak üzere Bilesik (I) gibi bir insülin sensitizörünün toksik olmayan etkili bir miktarinin buna ihtiyaç duyan bir insana veya insan olmayan bir memeliye uygulanmasini kapsayan, Tip 2 sekerli diabetin ve sekerli diabet ile ilintili durumlarin tedavisi için bir metod, böyle bir metodda kullanilacak terkipler ve bu gibi metodlarda kullanilacak aktif maddenin plazma konsantrasyonlarinin tespit edilmesi için bir metodoloji.
TR2001/01348T 1998-11-12 1999-11-12 Yeni tedavi metodu TR200101348T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9824893.3A GB9824893D0 (en) 1998-11-12 1998-11-12 Novel method of treatment

Publications (1)

Publication Number Publication Date
TR200101348T2 true TR200101348T2 (tr) 2002-02-21

Family

ID=10842389

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01348T TR200101348T2 (tr) 1998-11-12 1999-11-12 Yeni tedavi metodu

Country Status (40)

Country Link
EP (2) EP1135128B1 (tr)
JP (1) JP2003521455A (tr)
KR (2) KR20070048279A (tr)
CN (3) CN1235586C (tr)
AP (2) AP1580A (tr)
AR (2) AR029317A1 (tr)
AT (1) ATE366573T1 (tr)
AU (1) AU768303B2 (tr)
BG (2) BG65577B1 (tr)
BR (1) BR9915284A (tr)
CA (1) CA2350425C (tr)
CO (1) CO5150158A1 (tr)
CY (1) CY1106892T1 (tr)
CZ (1) CZ299801B6 (tr)
DE (1) DE69936533T2 (tr)
DK (1) DK1135128T3 (tr)
DZ (1) DZ2938A1 (tr)
EA (2) EA200700968A1 (tr)
ES (1) ES2289833T3 (tr)
GB (1) GB9824893D0 (tr)
HK (1) HK1041202B (tr)
HR (1) HRP20010344B1 (tr)
HU (1) HUP0104262A3 (tr)
IL (1) IL143088A0 (tr)
MA (1) MA26759A1 (tr)
MY (1) MY128347A (tr)
NO (1) NO328391B1 (tr)
NZ (1) NZ527132A (tr)
OA (1) OA12193A (tr)
PE (1) PE20001239A1 (tr)
PL (1) PL349421A1 (tr)
PT (1) PT1135128E (tr)
RS (1) RS50130B (tr)
SK (1) SK286357B6 (tr)
TR (1) TR200101348T2 (tr)
TW (1) TWI234456B (tr)
UA (1) UA79730C2 (tr)
UY (2) UY25797A1 (tr)
WO (1) WO2000027341A2 (tr)
ZA (1) ZA200103793B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125516A (en) 1999-11-16 2006-08-30 Smithkline Beecham Plc Novel composition based on thiazolidinedione and metformin and use
AU2002367154A1 (en) * 2001-12-21 2003-07-15 Smithkline Beecham Corporation Dosing regimen for ppar-gamma activators
WO2012074375A1 (en) * 2010-12-01 2012-06-07 N.V. Nutricia Prevention or treatment of overweight and obesity in type 2 diabetic patients

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
ES2137915T3 (es) * 1987-09-04 2000-01-01 Beecham Group Plc Derivados de tiazolidindiona sustituida.
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
GB8919417D0 (en) * 1989-08-25 1989-10-11 Beecham Group Plc Novel compounds
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH0469331A (ja) * 1990-07-10 1992-03-04 Asahi Chem Ind Co Ltd 徐放性エマルジョン製剤
JP2572673B2 (ja) * 1990-07-25 1997-01-16 エスエス製薬株式会社 徐放性錠剤
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
US5183823A (en) * 1991-04-11 1993-02-02 Takeda Chemical Industries, Ltd. Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents
FR2680512B1 (fr) * 1991-08-20 1995-01-20 Adir Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DK0601001T3 (da) * 1991-08-26 1997-10-20 Upjohn Co Flydende næringsmiddelprodukt indeholdende 3-guanidinopropionsyre.
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5506245A (en) * 1992-10-12 1996-04-09 Adir Et Compagnie Thiazolidinedione compounds
US5478853A (en) * 1992-10-12 1995-12-26 Adir Et Compagnie Thazolidinedione compounds
CA2115587A1 (en) * 1993-02-18 1994-08-19 Hayato Kihara Styrene copolymers, polystyrene compositions, processes for producing styrene copolymers, and injection-molded articles
DE4317320A1 (de) * 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
ATE376829T1 (de) * 1993-09-15 2007-11-15 Daiichi Sankyo Co Ltd Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm)
US5902726A (en) * 1994-12-23 1999-05-11 Glaxo Wellcome Inc. Activators of the nuclear orphan receptor peroxisome proliferator-activated receptor gamma
US5708012A (en) * 1995-04-28 1998-01-13 Sankyo Company, Limited Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of insulin resistant subjects with normal glucose tolerance in order to prevent or delay the onset of noninsulin-dependent mellitus
US5859037A (en) * 1997-02-19 1999-01-12 Warner-Lambert Company Sulfonylurea-glitazone combinations for diabetes
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes

Also Published As

Publication number Publication date
CN1235586C (zh) 2006-01-11
HK1041202B (zh) 2007-10-05
UY25797A1 (es) 2000-12-29
WO2000027341A3 (en) 2000-09-08
CN1354661A (zh) 2002-06-19
CA2350425C (en) 2009-06-02
JP2003521455A (ja) 2003-07-15
PL349421A1 (en) 2002-07-29
CZ299801B6 (cs) 2008-11-26
EP1135128B1 (en) 2007-07-11
MY128347A (en) 2007-01-31
AP2005003432A0 (en) 2005-12-31
CA2350425A1 (en) 2000-05-18
CY1106892T1 (el) 2012-01-25
NO20012301L (no) 2001-07-09
CZ20011656A3 (cs) 2002-06-12
AR029149A1 (es) 2003-06-18
NO20012301D0 (no) 2001-05-10
MA26759A1 (fr) 2004-12-20
EA200700968A1 (ru) 2008-06-30
ES2289833T3 (es) 2008-02-01
KR20010080440A (ko) 2001-08-22
DZ2938A1 (fr) 2004-03-15
KR20070048279A (ko) 2007-05-08
SK6422001A3 (en) 2001-12-03
BG105569A (en) 2002-01-31
HUP0104262A2 (en) 2002-08-28
SK286357B6 (sk) 2008-08-05
HRP20010344B1 (en) 2008-02-29
TWI234456B (en) 2005-06-21
IL143088A0 (en) 2002-11-10
UY25801A1 (es) 2000-08-21
GB9824893D0 (en) 1999-01-06
PE20001239A1 (es) 2000-12-24
WO2000027341A2 (en) 2000-05-18
CO5150158A1 (es) 2002-04-29
ATE366573T1 (de) 2007-08-15
CN1771943A (zh) 2006-05-17
RS50130B (sr) 2009-03-25
EA200100539A1 (ru) 2001-12-24
YU37401A (sh) 2005-07-19
NZ527132A (en) 2005-01-28
EP1135128A4 (en) 2003-07-16
PT1135128E (pt) 2007-10-12
BG110061A (bg) 2008-12-30
UA79730C2 (en) 2007-07-25
DE69936533T2 (de) 2008-03-13
AU1719600A (en) 2000-05-29
HRP20010344A2 (en) 2002-06-30
EP1135128A2 (en) 2001-09-26
BR9915284A (pt) 2002-02-13
HUP0104262A3 (en) 2003-06-30
DK1135128T3 (da) 2007-11-05
AR029317A1 (es) 2003-06-25
ZA200103793B (en) 2002-06-05
EA009192B1 (ru) 2007-12-28
AP1580A (en) 2006-02-24
AU768303B2 (en) 2003-12-04
CN101244062A (zh) 2008-08-20
EP1759698A1 (en) 2007-03-07
BG65577B1 (bg) 2009-01-30
HK1041202A1 (en) 2002-07-05
OA12193A (en) 2006-05-09
NO328391B1 (no) 2010-02-08
DE69936533D1 (de) 2007-08-23

Similar Documents

Publication Publication Date Title
Pedersen et al. Loss of force induced by high extracellular [K+] in rat muscle: effect of temperature, lactic acid and β2‐agonist
ATE260906T1 (de) Neue heterocyclische analoge von diphenylethylenverbindungen
DK0643775T3 (da) Quinonderivater til forbedring af cellebioenergi
WO2006111550A3 (fr) Procédé utilisant un capteur électrochimique et électrodes formant ce capteur
KR910007542A (ko) 폴리펩타이드의 서방형 조성물
BR9811609A (pt) Sensor eletroquìmico com áreas de elétrodo equalizadas
BR9903415A (pt) Composição para exterminação de artrópodes nocivos
EP0869356A3 (en) NOx sensor
ES2189539T3 (es) Composiciones de revestimiento endurecibles que contienen mezclas de compuestos con funcionalidad de carbamato.
TR200101348T2 (tr) Yeni tedavi metodu
TR199903095T2 (tr) Diabetin roziglitazon ve insülin ile tedavisi.
TR199800521T1 (tr) Seçimli beta3 adrenerjik agonistler.
DE50008507D1 (de) Mischung von pflanzenbehandlungsmitteln mit wachsen, verfahren zu deren herstellung und deren verwendung
Crawley et al. Spectroelectrochemical determination of the heterogeneous electron transfer kinetics of soluble spinach ferredoxin
Pecci et al. Reaction of rhodanese with dithiothreitol
MX9700198A (es) Compuestos peptidos de proinsulina para detectar y tratar diabetes tipo 1.
BR9915214A (pt) Combinações contendo um beta-agonista e umagente anti-diabético adicional
GB1503499A (en) Antiprotozoal method and composition
MX168979B (es) Poliolefinas estabilizadas contra degradacion oxidante con mezclas de diarilaminas sustituidas con aralquilo y fenoles estericamente impedidos
ES2059378T3 (es) Nuevos derivados de eter ciclicos, su preparacion y su uso.
KR830002799A (ko) 신규한 복소환식 안트라싸이클린 화합물의 제조방법
JPS57158718A (en) Dentifrice
JPS5635050A (en) Measuring method of substrate constant
UA67564A (en) Composition of the material of an ion-selective electrode for determining content of n,n-dimethyl-n,n-diallyl ammonium chloride
JPS5424089A (en) Oxygen concentration detector